An Observational Study Assessing the Treatment Response to Direct Acting Antiviral Agents in Patients with Severe HCV-related Cryoglobulinemic Glomerulonephritis
Latest Information Update: 22 Apr 2020
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Apr 2020 New trial record